| RPMGX | SPYGX | RPMGX / SPYGX | |
| Total Expense Ratio | 0.77 | 1.00 | 77% |
| Annual Report Gross Expense Ratio | 0.77 | 1.09 | 71% |
| Fund Existence | 34 years | 9 years | - |
| Gain YTD | 0.062 | -11.532 | -1% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 100000 | 3% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 20.8B | 941M | 2,210% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -5.63 | -13.14 | 43% |
| Returns for 3 years | -0.19 | 73.06 | -0% |
| Returns for 5 years | -24.20 | -13.10 | 185% |
| Returns for 10 years | 27.75 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GGOAX | 11.15 | 0.01 | +0.09% |
| Goldman Sachs Mid Cap Growth A | |||
| JOHAX | 29.76 | -0.01 | -0.03% |
| JOHCM International Select Investor | |||
| PRHSX | 94.44 | -0.31 | -0.33% |
| T. Rowe Price Health Sciences | |||
| THMEX | 16.85 | -0.07 | -0.41% |
| CCT Thematic Equity Institutional | |||
| BRSYX | 16.90 | -0.09 | -0.53% |
| MFS Blended Research Small Cap Eq R6 | |||